Prescient Therapeutics Limited (PSTTF) Discusses Clinical Progress of PTX-100 in Cancer Trials and Regulatory Milestones Transcript
Christian Riedel Hi there everybody. Welcome to the PTX Investor Briefing. Till…
OpenAI denies that it’s weighing a ‘last-ditch’ California exit amid regulatory pressure over its restructuring
In keeping with the WSJ, Openai executives are discussing potential relocations from…
